Mbd3 Promotes Reprogramming of Primary Human Fibroblasts by Jaffer, S et al.
eISSN 2005-5447
International Journal of Stem Cells Vol. 11, No. 2, 2018 https://doi.org/10.15283/ijsc18036
BRIEF REPORT
235
Received: April 23, 2018, Revised: April 23, 2018, 
Accepted: September 25, 2018, Published online: November 30, 2018 
Correspondence to Amit C Nathwani 
Department of Haematology, University College London, Cancer 
Institute, 72 Huntley Street, London, WC1E 6DD, UK
Tel: +44-(0)20-7794-0500, Fax: +44-(0)20-7472-6759 
E-mail: amit.nathwani@ucl.ac.uk
 This is an open-access article distributed under the terms of the Creative 
Commons Attribution Non-Commercial License (http://creativecommons.org/ 
licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-
tribution, and reproduction in any medium, provided the original work is 
properly cited.
Copyright ⓒ 2018 by the Korean Society for Stem Cell Research
Mbd3 Promotes Reprogramming of Primary Human Fibroblasts
Sajjida Jaffer1,2, Pollyanna Goh4, Mahnaz Abbasian1,2, Amit C Nathwani1,2,3
1Department of Haematology, University College London, Cancer Institute, London, UK
2Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free NHS Trust, London, UK
3National Health Services Blood and Transplant, Oak House, Reeds Crescent, Watford, Hertfordshire, UK
4Centre for Paediatrics, Barts and The London Medical School, Blizard Institute, Queen Mary University of London, London, UK
Mbd3 (Methyl-CpG binding domain protein), a core member of NuRD (nucleosome remodelling and deacetylation) 
is essential for embryogenesis. However, its role in reprogramming of somatic cells into induced pluripotent stem cells 
(iPSC) remains controversial. Some reports suggest that Mbd3 inhibits pluripotency, whilst others show that it greatly 
enhances reprogramming efficiency. Our study is the first to assess the role of Mbd3 on reprogramming of primary 
human fibroblasts using Yamanaka episomal plasmids (Reprogramming factors (RF) under feeder-free conditions. We 
showed that shRNA-mediated partial depletion of Mbd3 resulted in ＞5-fold reduction in the efficiency of reprogram-
ming of primary human fibroblasts. Furthermore, iPSC that emerged after knock-down of Mbd3 were incapable of 
trilineage differentiation even though they expressed all markers of pluripotency. In contrast, over-expression of the 
Mbd3b isoform along with the Yamanaka episomal plasmids increased the number of fibroblast derived iPSC colonies 
by at least two-fold. The resulting colonies were capable of trilineage differentiation. Our results, therefore, suggest 
that Mbd3 appears to play an important role in reprogramming of primary human fibroblasts, which provides further 
insight into the biology of reprogramming but also has direct implication for translation of iPSC to clinic. 
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Introduction 
  The pioneering work by Takahashi and Yamanaka 
showed that induced pluripotent stem (iPSC) cells can be 
generated from somatic cells by ectopic expression of four 
different transcription factors, originally Oct4, Sox2, Klf4 
and Myc (1-3). Understanding the molecular mechanisms 
that regulate the pluripotency and self-renewal of iPSC is 
critical for regenerative medicine in generating target cells 
for transplantation. Reprogramming requires major epi-
genetic modifications of DNA and chromatin remodelling 
and several groups are investigating the role of Nucleo-
some Remodelling and Histone Deacetylase (NuRD) com-
plex and in particular Mbd3 (Methyl-CpG binding domain 
protein). Mbd3 is ubiquitously expressed in all somatic 
cells and is required for formation of stable NuRD com-
plex (4). Deletion of the Mbd3 gene causes embryonic le-
thality in mice. Additionally, embryonic stem cells lacking 
Mbd3 protein fail to commit to developmental lineages (4, 
5). Whilst it is clear that Mbd3 is required for early embry-
onic development and stem cell fate decisions, its exact 
role in somatic cell reprogramming is currently unclear. 
Two reports suggest that Mbd3 inhibits pluripotency as its 
reduction or deletion leads to an enhanced kinetics of re-
programming with iPSC colonies appearing within 7 days 
and with an almost 100% reprogramming efficiency (6, 7). 
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In contrast, a study by dos Santos et al. (8), showed that 
loss of Mbd3 expression, especially, during the initiation 
phase of reprogramming leads to a reduction in the effi-
ciency of reprogramming. It is unclear if these disparate 
results reflect the different reprograming techniques used 
or a function of the target cells. 
  Here, we investigated the role of Mbd3 in direct re-
programming of primary human fibroblasts using epi-
somal-plasmid based method (2, 3). Our results show that 
over-expression of Mbd3b significantly increased the yield 
of iPSC colonies and reduction of Mbd3 expression not on-
ly reduced the yield of iPSC colonies but repressed sub-
sequent trilineage differentiation. Our findings suggest 
that Mbd3 plays a critical role in reprogramming of pri-
mary human fibroblasts at least in the context of epi-
somal-based method of reprogramming. 
Materials and Methods
Cell culture
  All human primary fibroblast cells were generated in vi-
tro after written informed consent using protocols ap-
proved by the Royal Free research ethics committee, Royal 
Free Hospital, London, UK. Fibroblasts were derived 
from a skin biopsy and cultured as described previously 
(3). We used PD1 (70 year old suffering from Parkinson 
disease) and RDP1 (49 year old with rapid onset 
Parkinsonism dystonia) as described previously (3). We al-
so used BJ fibroblast cell line (a normal neonatal fibro-
blast cell line from ATCC). 
  We employed episomal plasmid method of reprogram-
ming as described previously (2, 3) and used the following 
plasmids: pCXLE-hOct3/4-shp53 (Addgene number 
27077), pCXLE-hSK (Addgene number 27078), pCXLE- 
hUL (Addgene number 27080), (the latter three referred 
to as reprogramming factors- (RF)), and pCXLE-EGFP 
(Addgene number 27082). For inhibition of Mbd3, we 
used pSMP-MBD3_1 (Addgene number 36371) (9). The 
Mbd3 isoform that we used for over-expression experi-
ments was Mbd3b (8) which shares ＞80% homology to hu-
man Mbd3 (10) and is the most abundant isoform in em-
bryonic stem cells (11). The outline of experiments is 
summarized in Fig. 1A. Briefly, cells were transfected us-
ing program U-023 on a Nucleofector (I) 2b device 
(Amaxa Nucleofector kit R) or Pulse code – EO150 
(solution P2) on AMAXA 4D Nucleofector (LONZA). 
GFP transfection efficiency was measured using flow cy-
tometry after a minimum of 24 hours of transfection. 
Established iPSC cell lines were maintained as described 
previously (3) and were passaged at 1：1∼1：12 using 
gentle cell dissociation reagent (12). At day 25∼30 post 
transfection, cells were either fixed for whole plate alka-
line phosphatase staining as per manufacturer’s instruc-
tions or iPSC colonies were picked for expansion. 
Immunoblotting
  Immunoblotting was carried out as described previously 
(13). The blots were probed either with Mbd3 (ABCAM), 
α-tubulin (ABCAM), or GAPDH (Cell Signalling). 
Densitometry was performed using NIH image J software 
and a sampling window was used to measure the intensity 
of all bands on the blot and normalized against the band 
intensity of the internal control. 
Characterisation of iPSC
  Immunofluorescence was carried on established iPSC 
cell lines as described previously (3). Primary antibodies 
namely TRA-1-60 and TRA-1-80 (Santa Cruz Biotechnolo-
gies) were used at a 1：100 dilution followed by goat an-
ti-mouse IgG/IgM Alexa 488 as a secondary antibody at 
a concentration of 1：400. The cells were visualised using 
Axiovision microscope equipped with 10× objective. For 
established iPSC cell lines, RNA was harvested with 
TRIzol and 1μg of RNA was used for subsequent reverse 
transcriptase reactions with Superscript III first strand 
synthesis system. For qRT-PCR cDNA was diluted in 1 
in 20 and were set up in duplicates using SYBR Green 
Master Mix. Delta Ct values with GAPDH were calculated 
and brought to power -2. Error bars represent±SEM of 
technical duplicates. Oligonucleotide primers details have 
been described elsewhere (3). To demonstrate spontaneous 
in vitro differentiation, iPSC were grown to confluency 
and maintained in suspension in EB media. The ex-
pression of trilineage marker genes were assayed after 14 
days of differentiation (3). Statistical significance was de-
termined by non-parametric Mann-Whitney U-test and in 
all cases p≤0.05 was considered to be significant 
(Supplementary Methods).
Results
Mbd3 is required for reprogramming of primary human 
fibroblasts 
  In order to assess the role of Mbd3 in establishment of 
pluripotency of human somatic cells, a plasmid construct 
expressing short-hairpin (shp) RNA targeted to human 
Mbd3 transcript (shpMbd3) was transfected together with 
Yamanaka episomal plasmids expressing human Oct3/4, 
shRNA against p53, Sox2, Klf4 and L-Myc/Lin28 (referred 
to as RF) in BJ foetal fibroblast cell line and two adult 
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Fig. 1. Mbd3 is required for Episomal Reprogramming. (A) Experimental design used to address the kinetics and efficiency of reprogramming 
in human dermal fibroblasts. Human fibroblasts were transfected with episomal plasmids encoding pCXLE-hOct3/4-shp53, pCXLE-hSK (Sox-2 
and Klf4) and pCXLE-hUL (L-Myc and Lin28) (Reprogramming factors-RF) or RF+shpMbd3 or RF+Mbd3b or GFP only. After transfection, 
the cells were maintained in Essential 8 media supplemented with 0.5mM sodium butyrate until day 12 and thereafter maintained in Essential 
8 media only. Transfection efficiency was measured by Flow Cytometry after a minimum of 24 hours of transfection with an average 
of 32.8±1.68%. (B) Immunoblot analysis for Mbd3 expression transfected with shpMbd3 compared to sham. Densitometry plot shows 
that cells transfected with shpMbd3 had 50% reduction in expression of Mbd3 compared to sham (p＜0.05). (C) iPSC colony formation 
in fibroblasts was assessed by alkaline phosphatase (AP) staining between day 25∼30 and the results showed that shpMbd3 reduced the 
number of iPSC colonies. (D) Quantification of AP staining further confirmed reduction of iPSC colonies formed in cells treated with 
RF+shpMbd3 compared with RF in patient fibroblasts RPD1 and PD1 and BJ neonatal cell line (n=3). Colony number is per 1×106 fibro-
blasts (p＜0.05). 
patient derived fibroblast lines; PD1 (70 years old with 
Parkinson’s disease) and RDP1 (49 years old with rapid 
onset of Parkinsonism dystonia) (Fig. 1A). GFP trans-
fection efficiency of all three lines was comparable with 
mean (±SD) expression levels of 32.8±1.68%. Immuno-
blotting after 24∼48 hours of transfection showed 50% 
knock-down of Mbd3 compared to sham (p＜0.05) (Fig. 
1B), but did not result in a difference in the proliferation 
rate of cells transfected with RF+shpMbd3 when com-
pared with cells transfected with RF alone as seen 
morphologically. This suggests that partial knock-down of 
Mbd3 does not cause cell cycle arrest (8) of human fibro-
blasts, however, cell cycle analysis are required to further 
confirm this. iPSC colonies emerged at approximately the 
same time (days 12∼20 post transfection) in the cells 
transfected with RF+shpMbd3 and RF alone cultures sug-
gesting that Mbd3 does not alter the kinetics of reprogram-
ming as reported previously (8). We used alkaline phos-
phatase activity as an early indicator of pluripotency prior 
to performing an extended assessment of pluripotent stem 
cell markers (14). Our results showed that the number of 
alkaline phosphatase positive colonies in cells transfected 
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Fig. 2. Characterisation of iPSC colonies. (A) Representative 
phase images of iPSC derived from fibroblasts transfected 
RF and cells transfected with RF+shpMbd3. Morphologi-
cally they appear to be similar. Immunostaining with pluri-
potency markers (green) and counter staining with DAPI 
(blue) of iPSC derived from fibroblasts transfected with RF 
only and those transfected with RF+shpMbd3 with 
TRA-1-81 and TRA-1-60. Scale bar is 200μm. (B) Q-PCR 
showed expression of pluripotency genes (Oct-4 and 
Nanog respectively) in cells treated with RF and RF+ 
shpMbd3. All results were normalised to GAPDH. (n=3 
Error bars±S.E.M). (C) Q-PCR showed up- regulation of li-
neage specific genes: Cdx2 (mesoderm), Pax6 (ectoderm) 
and MixI (endoderm) in cells treated with RF embryoid 
bodies relative to respective iPSC line (n=3 Error bars± 
S.E.M).
with RF+shpMbd3 was significantly reduced (p＜0.05) by 
5∼33 fold in established BJ fibroblast cell line and in 
PD1 and RPD1 primary fibroblast cells compared to the 
numbers observed with cells transfected with RF alone (BJ 
mean (±SD): RF 200±52.9 and RF+shpMbd3 35±6.8; 
RPD1 mean (±SD): RF 24±4.2 and RF+shpMbd3 0±0; 
PD1 mean (±SD): RF 65±1.5 and RF+shpMbd3 2±1; 
(n=3) Fig. 1C, D). Interestingly, this effect was more pro-
found in patient derived fibroblasts than in neonatal BJ 
fibroblast cell-line. The reason for this difference is un-
clear but could reflect the biological age of these lines and 
disease status of the patients. It was however, possible to 
expand iPSC colonies from cells treated with RF+ 
shpMbd3 although less efficiently and with delayed ki-
netics compared to colonies expanded from cells treated 
with RF only. Phenotypic characterisation of expanded 
iPSC colonies showed that they expressed TRA-1-60 and 
TRA-1-80 pluripotent markers with no difference in level 
of expression between cells treated with RF+shpMbd3 
and RF only (Fig. 2A). Additionally, qRT-PCR analysis 
showed that iPSCs expanded from RF and RF+shpMbd3 
expressed pluripotent genes such as Oct-4 and Nanog (Fig. 
2B) at comparable levels. To investigate the role of NuRD 
in differentiation, iPSCs were maintained in suspension 
in EB media and under these conditions iPSCs formed ag-
gregates called embryoid bodies which consists of a heter-
ogeneous mix of derivatives of the three germ layers. 
iPSCs derived from RF+shpMbd3 failed to form EBs as 
previous reports (4). In contrast, EBs emerged from RF 
iPSCs with evidence of expression of trilineage markers 
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Fig. 3. Over-expression of Mbd3b facilitates reprogramming. (A) Immunoblot analysis for cells over-expressing Mbd3b compared to sham. 
Densitometry plot showed that cells over-expressing Mbd3b increased its expression by almost 50% compared to sham (p＜0.05). (B) 
Quantification of iPSC colonies generated from fibroblasts transfected with RF+Mbd3b compared to cells treated with RF in BJ neonatal 
cell line and patient fibroblasts (RPD1 and PD1). A two fold increase is seen in the number of colonies in RF+Mbd3b compared to RF 
only (p＜0.05). (C) Representative phase images of iPSC of established cell lines transfected with RF and RF+Mbd3b. Immunostaining 
with pluripotency markers (green) and counter staining with DAPI (blue) of cells treated with RF and RF+Mbd3b with TRA-1-81 and 
TRA-1-60. Scale bar is 200μm. (Error bars±S.E.M). (D) Q-PCR showed expression of pluripotency genes (Oct-4, Nanog and Sox-2 re-
spectively) in cells treated with RF and RF+Mbd3b. All results were normalised to GAPDH (n=3 Error bars±S.E.M). (E) Representative 
images of embryoid bodies (EBs) generated from RF (left), and RF+Mbd3b (right). (F) Q-PCR showed up-regulation of lineage specific genes: 
Cdx2 (mesoderm), Pax6 (ectoderm) and MixI (endoderm) in conditions treated with RF EBs and RF+Mbd3b EBs (G) relative to respective 
iPSC line. 
such as Cdx2 (mesoderm), Pax6 (ectoderm) and MixI 
(endoderm) by qRT-PCR analysis (Fig. 2C). 
Over-expression of Mbd3b enhances reprogramming 
of human fibroblasts
  We next looked at over-expression of Mbd3b, a major 
isoform expressed in pluripotent stem cells (8, 11) and 
confirmed by immunoblotting an approximately 50% sig-
nificant increase in the levels of Mbd3b (Fig. 3A). An al-
most two-fold significant (p＜0.05) increase in the number 
of alkaline phosphatase colonies was observed in cultures 
transfected with RF+Mbd3b when compared with RF 
alone (Fig. 3B) (BJ: RF 155±5 and RF+Mbd3b 290±10; 
RPD1: RF 30±1.5 and RF+Mbd3b 64±1.3; PD1: RF 
70±2.0 and RF+Mbd3b 150±1.0). iPSC colonies emerged 
at approximately the same time in cells treated with 
RF+Mbd3b and in RF alone cultures and the overall pro-
liferation kinetics of iPSC between these two conditions 
were similar (data not shown). iPSC clones from both 
these conditions expressed pluripotent markers (TRA-1-81 
and TRA-1-60) with evidence of endogenous expression of 
Nanog, Oct 4 and Sox 2 by qRT-PCR (Fig. 3C, D) with 
no difference in level of expression. Importantly, iPSCs 
derived from fibroblasts transfected with RF+Mbd3b 
formed EBs with comparable kinetics to that observed 
with cells treated RF alone (Fig. 3E) and expressed mark-
ers indicative of the three germ layers (Fig. 3F, G).
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Discussion
  Our study is the first to investigate the role of Mbd3 
in the induction of pluripotency in patient derived pri-
mary fibroblasts, a convenient source of cells for iPSC 
cell-based therapies. Therefore, the identification of fac-
tors that enhance reprogramming efficiency of primary fi-
broblast derived lines will have direct clinical relevance 
(3). Our results show that partial knock-down of Mbd3 in 
human fibroblasts reduced the reprogramming efficiency. 
The iPSCs expanded from fibroblasts transfected with 
RF+shpMbd3 displayed all the hallmarks of pluripotency 
suggesting that Mbd3 is not required for the establishment 
of pluripotency as reported previously (7, 8). However, the 
iPSCs expanded and derived from fibroblasts treated with 
RF+shpMbd3 failed to form EBs confirming that Mbd3 
is essential for forward differentiation into trilineage pro-
genitors (4, 8). 
  In contrast, we found that over-expressing Mbd3b along 
with Yamanaka episomal plasmids enhances reprogram-
ming efficiency by a two-fold. Whilst both forms of Mbd3 
(Mbd3a and Mbd3b) interact with NuRD components, 
over-expression of Mbd3b has been shown to result in 
more pronounced phenotype than other isoforms in re-
versing the effects of knock-down of Mbd3 (11). Our re-
sults showed that over-expression of Mbd3b along with RF 
increased the number of iPSC cell colonies formed with-
out affecting the attributes of pluripotency including the 
ability generate embryoid bodies with evidence of triline-
age differentiation. The in-vitro differentiation potential in 
this study provides with robust reproducible alternative to 
teratoma assay and is sensitive enough to assess the pluri-
potency characteristics of iPSCs (15). However, further 
studies in a teratoma model are nevertheless required to 
establish this aspect in an unequivocal manner.
  Our results reported herein are in agreement with re-
ports by Onder et al.; 2012 (9) dos Santos et al.; 2014 (8, 
9) and Zhang et al.; 2016 (16) but are at odds with two 
other reports (6, 7). In our opinion, the latter studies are 
not directly comparable as they used different methods of 
reprogramming and target cell lines. However, future 
studies are required to show the effect of Mbd3 using ret-
rovirus or lentiviral method of reprogramming fibroblasts. 
Interestingly, others have shown that the Mbd3-miR-134 
axis plays a key role in induction of pluripotency with 
Mbd3 overcoming the repression of reprogramming 
caused by over-expression of miR-134 (16). How this hap-
pens is under investigation with recent data showing an 
interdependence among Mbd3/NuRD, Tet1 and 5hmC to 
maintain normal chromatin structure and gene regulation 
in pluripotent stem cells (17). 
  We, therefore, conclude that Mbd3 plays an important 
role in reprogramming of human fibroblast cells using the 
episomal plasmid-based system of reprogramming. Under-
standing detailed molecular mechanism of Mbd3 in re-
programming and their function in enhancing the repro-
gramming efﬁciency are worthy of further investigation, 
and will be helpful in deriving excellent quality of iPSCs 
to facilitate clinical application.
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